Colo-rectal Cancer trials recruiting in Kansas

Fewer than 3 recruiting trials found.

All Colo-rectal Cancer trials nationally

Cities in Kansas

Recruiting trials in Kansas

• A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
  NCT07058012 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Shield Post-Approval Study Protocol
  NCT06880055 · Phase: Not specified · Ages: 45 Years to 81 Years · Sex: All (male and female) · Kansas: Hutchinson